Plasma proteomics biomarkers for predicting anti‐tuberculosis drug‐induced liver injury: A comprehensive assessment
This study has successfully identified five pre-treatment plasma protein signature that, when incorporated into machine learning models, may enable the prediction of ATB-DILI risk, offering potential for early intervention in tuberculosis therapy.
Authors
- Jian‐Qing He (ORCID: https://orcid.org/0000-0002-0966-1302)
- Mei Zhang (ORCID: https://orcid.org/0000-0002-3141-747X)
- M. Wang (ORCID: https://orcid.org/0000-0002-4713-9646)
- Quan‐Xian Liu
Institutions
- GenVec (US)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1002/bcp.70446
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00